vs
PRECIGEN, INC.(PGEN)与Rithm Property Trust Inc.(RPT)财务数据对比。点击上方公司名可切换其他公司
Rithm Property Trust Inc.的季度营收约是PRECIGEN, INC.的1.9倍($3.4M vs $1.8M),Rithm Property Trust Inc.净利率更高(95.4% vs -1149.9%,领先1245.3%),PRECIGEN, INC.同比增速更快(-39.3% vs -39.7%)
Precigen是一家美国生物技术企业,由Helen Sabzevari担任总裁兼首席执行官,专注于生物技术领域的相关研发与业务布局,在行业内拥有自身的技术积累与发展优势。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司,核心业务聚焦于房地产投资及另类投资领域,是该赛道颇具影响力的专业投资机构。
PGEN vs RPT — 直观对比
营收规模更大
RPT
是对方的1.9倍
$1.8M
营收增速更快
PGEN
高出0.4%
-39.7%
净利率更高
RPT
高出1245.3%
-1149.9%
损益表 — Q2 FY2023 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.8M | $3.4M |
| 净利润 | $-20.3M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | -1153.6% | 99.6% |
| 净利率 | -1149.9% | 95.4% |
| 营收同比 | -39.3% | -39.7% |
| 净利润同比 | -15.2% | 11.2% |
| 每股收益(稀释后) | $-0.08 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PGEN
RPT
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $249.0K | ||
| Q3 23 | — | $1.1M | ||
| Q2 23 | $1.8M | — | ||
| Q1 23 | $1.9M | $540.0K | ||
| Q4 22 | $1.8M | $1.4M |
净利润
PGEN
RPT
| Q4 25 | — | $3.2M | ||
| Q3 25 | — | $-273.0K | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $-3.4M | ||
| Q3 23 | — | $-5.5M | ||
| Q2 23 | $-20.3M | — | ||
| Q1 23 | $-22.7M | $-7.4M | ||
| Q4 22 | — | — |
营业利润率
PGEN
RPT
| Q4 25 | — | 99.6% | ||
| Q3 25 | — | -6.2% | ||
| Q2 25 | — | 45.7% | ||
| Q1 25 | — | -1416.5% | ||
| Q3 23 | — | -533.4% | ||
| Q2 23 | -1153.6% | — | ||
| Q1 23 | -1231.2% | -1346.5% | ||
| Q4 22 | — | — |
净利率
PGEN
RPT
| Q4 25 | — | 95.4% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | -1363.1% | ||
| Q3 23 | — | -526.3% | ||
| Q2 23 | -1149.9% | — | ||
| Q1 23 | -1228.2% | -1369.3% | ||
| Q4 22 | — | — |
每股收益(稀释后)
PGEN
RPT
| Q4 25 | — | $-0.26 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q3 23 | — | $-0.25 | ||
| Q2 23 | $-0.08 | — | ||
| Q1 23 | $-0.10 | $-0.34 | ||
| Q4 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $166.2M | $291.6M |
| 总资产 | $207.5M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PGEN
RPT
| Q4 25 | — | $79.3M | ||
| Q3 25 | — | $81.4M | ||
| Q2 25 | — | $98.6M | ||
| Q1 25 | — | $97.4M | ||
| Q3 23 | — | $63.9M | ||
| Q2 23 | $88.4M | — | ||
| Q1 23 | $104.1M | $49.4M | ||
| Q4 22 | $56.0M | $47.8M |
总债务
PGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | $43.2M | — |
股东权益
PGEN
RPT
| Q4 25 | — | $291.6M | ||
| Q3 25 | — | $291.7M | ||
| Q2 25 | — | $294.7M | ||
| Q1 25 | — | $296.1M | ||
| Q3 23 | — | $320.2M | ||
| Q2 23 | $166.2M | — | ||
| Q1 23 | $184.1M | $330.4M | ||
| Q4 22 | $126.3M | $335.3M |
总资产
PGEN
RPT
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q3 23 | — | $1.4B | ||
| Q2 23 | $207.5M | — | ||
| Q1 23 | $241.5M | $1.4B | ||
| Q4 22 | $216.0M | $1.5B |
负债/权益比
PGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-15.8M | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.9M | — |
| 自由现金流率自由现金流/营收 | -898.1% | — |
| 资本支出强度资本支出/营收 | 5.7% | — |
| 现金转化率经营现金流/净利润 | — | -2.56× |
| 过去12个月自由现金流最近4个季度 | $-129.8M | — |
8季度趋势,按日历期对齐
经营现金流
PGEN
RPT
| Q4 25 | — | $-8.3M | ||
| Q3 25 | — | $-5.8M | ||
| Q2 25 | — | $-25.0K | ||
| Q1 25 | — | $-1.6M | ||
| Q3 23 | — | $-10.7M | ||
| Q2 23 | $-15.8M | — | ||
| Q1 23 | $-18.4M | $-16.8M | ||
| Q4 22 | $-65.0M | $1.1M |
自由现金流
PGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $-15.9M | — | ||
| Q1 23 | $-18.5M | — | ||
| Q4 22 | $-70.0M | $1.1M |
自由现金流率
PGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -898.1% | — | ||
| Q1 23 | -1001.7% | — | ||
| Q4 22 | -3968.7% | 80.6% |
资本支出强度
PGEN
RPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 23 | — | 0.0% | ||
| Q2 23 | 5.7% | — | ||
| Q1 23 | 8.3% | — | ||
| Q4 22 | 279.3% | 2.0% |
现金转化率
PGEN
RPT
| Q4 25 | — | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图